LETZICARE 2.5MG is a prescription medication that contains Letrozole, a potent aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. By inhibiting the aromatase enzyme, LETZICARE 2.5MG effectively reduces estrogen levels in the body, which can slow or stop the growth of estrogen-dependent tumors.
Usage:
LETZICARE 2.5MG is typically prescribed for adjuvant treatment in early-stage breast cancer or for metastatic breast cancer. It is often recommended after other treatments, such as tamoxifen, to prevent cancer recurrence or progression.
Side Effects:
Common side effects of LETZICARE 2.5MG include hot flashes, fatigue, joint pain, and nausea. More serious but less common side effects may include bone thinning (osteoporosis), heart problems, and severe allergic reactions. Patients should report any unusual symptoms to their healthcare provider. Regular monitoring is advised to manage potential side effects effectively.